AS

Atul Sharma

Active Director Director DIN 09211387
DIN 09211387 First appointment Jun 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2021
Shareholding value •••• Premium profile

About Atul Sharma

Data last updated:

Atul Sharma is a Director at Wylen Biosciences Private Limited (since 2021). The company operates in Chemicals. Wylen Biosciences Private Limited reported revenue of ₹9.2 Lakh (FY 2025).

DIN 09211387
Primary Designation Director
Industry Chemicals
First Appointment 22 Jun 2021
Oldest Company Age 5 yrs
Largest company Wylen Biosciences Private Limited · ₹9.2 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Wylen Biosciences Private Limited U24110RJ2021PTC075459
Director22 Jun 20212021₹9.2 Lakh (FY 2025)Active

Board colleagues of Atul Sharma

NameDINCompanyDesignation
Seema Sharma09211388Wylen Biosciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Wylen Biosciences Private Limited
Premium access

Shareholding and investment profile for Atul Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Atul Sharma

Atul Sharma currently holds 1 directorship: Wylen Biosciences Private Limited (Director, since 22 Jun 2021, revenue ₹9.2 Lakh (FY 2025)).

Atul Sharma was first appointed on 22 Jun 2021 as Director at Wylen Biosciences Private Limited.

The current boards of Atul Sharma's companies include Seema Sharma (Wylen Biosciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available